Relay Therapeutics, Inc. (RLAY) Tops Q1 EPS by 12c

Relay Therapeutics, Inc. (NASDAQ: RLAY) reported Q1 EPS of ($0.62), $0.12 better than the analyst estimate of ($0.74). Revenue for the quarter came in at $10 million versus the consensus estimate of $111.11 thousand.

For earnings history and earnings-related data on Relay Therapeutics, Inc. (RLAY) click here.

You May Also Be Interested In

• Activist investor presses Xerox to review financial services arm - Bloomberg
• Braze, Inc. (BRZE) Tops Q2 EPS by 4c; offers guidance
• Canaan Inc. (CAN) PT Lowered to $2 at BTIG